Skip to main content

Table 3 Prognostic influence of clinical and serologic parameters on hearing gain (∆6PTA) ≥10 dB absolute hearing gain

From: Prognostic impact of standard laboratory values on outcome in patients with sudden sensorineural hearing loss

Parameter Δ6PTA <>10 dBp
Gender 0.160
Age 0.176
Side 0.624
Tinnitus 0.133
Vertigo 0.574
Smoker 0.586
Comorbidity (Charlson Index ≥1) 0.435
Vascular risk factor 0.402
Low-frequency hearing loss <0.0001
Start of inpatient treatment <4 days after onset 0.018
Interval between first and last audiogram 0.065
First SSNHL 0.001
Contralateral ear with normal hearing 0.159
Initial hearing loss ≥ 60 dB <0.0001
aPTT, normal 0.905
Quick, lower than normal 0.040
Fibrinogen (g/l), high (hyperfibrinogenemia) 0.007
Red-cell count (Tptl/l) women 0.611
Red-cell count (Tptl/l) men 0.593
Hemoglobin (mmol/l) women 0.901
Hemoglobin (mmol/l) men 0.946
Hematocrit women 0.727
Hematocrit men 0.086
White-cell count (/μl) 0.433
Platelet count (Gpt/l) 0.749
MCH 0.456
MCHC 0.445
MCV 0.582
Glucose (mmol/l) 0.078
Sodium (mmol/l) 0.656
Potassium (mmol/l) 0.164
Calcium (mmol/l) 0.273
Urea (mmol/l) 0.694
Creatinine (lmol/l) women 0.116
Creatinine (lmol/l) men 0.497
C-reactive protein (mg/l) 0.380
Cholesterol (mmol/l) 0.088
LDL (mmol/l) 0.131
HDL (mmol/l) 0.922
LDL/HDL 0.367
Triglycerides (mmol/l) 0.970
  1. p values in bold are p values below 0.05, i.e. significant p values.